🇺🇸 FDA
Patent

US 7034016

8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives

expired A61PA61P1/00A61P11/00

Quick answer

US patent 7034016 (8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives) held by Almirall Prodesfarma S.A. expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Almirall Prodesfarma S.A.
Grant date
Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P1/00, A61P11/00, A61P11/06, A61P13/12